
WHO decision on Covaxin EUA in September
The Hindu
A top vaccines official at the World Health Organization says the agency expects to make a decision in September on an emergency use authorisation for the Indian-made COVID-19 vaccine made by Bharat B
A top vaccines official at the World Health Organization says the agency expects to make a decision in September on an emergency use authorisation for the Indian-made COVID-19 vaccine made by Bharat Biotech, a shot that has yet to be authorised by any Western regulatory authorities. Mariangela Simao, a WHO Assistant Director-General for vaccines, says the UN health agency’s assessment of the Bharat Biotech vaccine was “quite advanced” and officials hoped for a decision by mid-September. Few studies have been published on the shot. Indian researchers have yet to share any advanced research about the vaccine, which has been authorised and used in India.More Related News

The Karnataka government has drafted a comprehensive master plan for the integrated development of Kukke Subrahmanya temple, the State’s highest revenue-generating temple managed by the Hindu Religious Institutions and Charitable Endowments Department. The redevelopment initiative is estimated to cost around ₹254 crore and aims to enhance infrastructure and facilities for devotees.